UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

Clinical microbiology and infection, 2021-11, Vol.27 (11), p.1652-1657

2021

Link zum Volltext

Verfügbarkeit prüfen

A cat’s scratch or a wolf’s bite?

Lupus, 2020-10, Vol.29 (11), p.1469-1471

2020

Link zum Volltext

Verfügbarkeit prüfen

Structure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 Å resolution

Nature communications, 2018-09, Vol.9 (1), p.3886-6, Article 3886

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

PloS one, 2022-07, Vol.17 (7), p.e0271036-e0271036

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2518-2523

2012

Link zum Volltext

Verfügbarkeit prüfen

Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022

Emerging infectious diseases, 2023-07, Vol.29 (7), p.1302-1301

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records

PloS one, 2020-01, Vol.15 (1), p.e0226515-e0226515

2020

Link zum Volltext

Verfügbarkeit prüfen

Partial Oral Therapy for Osteomyelitis and Endocarditis

The New England journal of medicine, 2019-09, Vol.381 (12), p.1183

Zimhony, Oren

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic

International journal of infectious diseases, 2023-07, Vol.132, p.72-79

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply to Focosi et al

Clinical infectious diseases, 2023-11, Vol.77 (9), p.1357-1358

2023

Link zum Volltext

Verfügbarkeit prüfen

Ritual Slaughter as Overlooked Risk Factor for Brucellosis

Emerging infectious diseases, 2016-04, Vol.22 (4), p.746-748

2016

Link zum Volltext

Verfügbarkeit prüfen

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

EClinicalMedicine, 2020-09, Vol.26, p.100525-100525, Article 100525

2020

Link zum Volltext

Verfügbarkeit prüfen

Rapid Phenotypic Antibiotic Susceptibility Profiling of Clinical Escherichia coli and Klebsiella pneumoniae Blood Cultures

Antibiotics (Basel), 2024-02, Vol.13 (3), p.231

2024

Link zum Volltext

Verfügbarkeit prüfen

Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli

PloS one, 2018-09, Vol.13 (9), p.e0204457-e0204457

2018

Link zum Volltext

Verfügbarkeit prüfen

An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: From theory to practice

American journal of infection control, 2011-10, Vol.39 (8), p.671-677

2011

Link zum Volltext

Verfügbarkeit prüfen

The Unexpected Essentiality of glnA2 in Mycobacterium smegmatis Is Salvaged by Overexpression of the Global Nitrogen Regulator glnR , but Not by L-, D- or Iso-Glutamine

Frontiers in microbiology, 2018-09, Vol.9, p.2143-2143

2018

Link zum Volltext

Verfügbarkeit prüfen

Bartonella koehlerae, a New Cat-Associated Agent of Culture-Negative Human Endocarditis

Journal of Clinical Microbiology, 2004-08, Vol.42 (8), p.3462-3468

2004

Link zum Volltext

Verfügbarkeit prüfen

Pyrazinoic Acid and Its n-Propyl Ester Inhibit Fatty Acid Synthase Type I in Replicating Tubercle Bacilli

Antimicrobial Agents and Chemotherapy, 2007-02, Vol.51 (2), p.752-754

2007

Link zum Volltext

Verfügbarkeit prüfen

Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort Study

Journal of fungi (Basel), 2022-07, Vol.8 (7), p.721

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Isolated Mycobacterium tuberculosis Fatty Acid Synthase I by Pyrazinamide Analogs

Antimicrobial Agents and Chemotherapy, 2007-07, Vol.51 (7), p.2430-2435

2007

Link zum Volltext

Verfügbarkeit prüfen

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

Nature medicine, 2000-09, Vol.6 (9), p.1043-1047

2000

Link zum Volltext

Verfügbarkeit prüfen

Endocarditis Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae: Emergence of Resistance to Ciprofloxacin and Piperacillin-Tazobactam during Treatment despite Initial Susceptibility

Antimicrobial Agents and Chemotherapy, 2006-09, Vol.50 (9), p.3179-3182

2006

Link zum Volltext

Verfügbarkeit prüfen

Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity

AIDS (London), 2016-02, Vol.30 (4), p.671-672

2016

Link zum Volltext

Verfügbarkeit prüfen

Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing Strategy

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.5323-5328

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(90)
Berichte
(1)

Sprache

Englisch
(91)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

A cat’s scratch or a wolf’s bite?

Structure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 Å resolution

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection

Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022

Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors

Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records

Partial Oral Therapy for Osteomyelitis and Endocarditis

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic

Reply to Focosi et al

Ritual Slaughter as Overlooked Risk Factor for Brucellosis

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Rapid Phenotypic Antibiotic Susceptibility Profiling of Clinical Escherichia coli and Klebsiella pneumoniae Blood Cultures

Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli

An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: From theory to practice

The Unexpected Essentiality of glnA2 in Mycobacterium smegmatis Is Salvaged by Overexpression of the Global Nitrogen Regulator glnR , but Not by L-, D- or Iso-Glutamine

Bartonella koehlerae, a New Cat-Associated Agent of Culture-Negative Human Endocarditis

Pyrazinoic Acid and Its n-Propyl Ester Inhibit Fatty Acid Synthase Type I in Replicating Tubercle Bacilli

Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort Study

Inhibition of Isolated Mycobacterium tuberculosis Fatty Acid Synthase I by Pyrazinamide Analogs

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

Endocarditis Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae: Emergence of Resistance to Ciprofloxacin and Piperacillin-Tazobactam during Treatment despite Initial Susceptibility

Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity

Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing Strategy

Suchergebnisse filtern